Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis

American Journal of Pathology

Volumn 161, Issue 3, 2002, Pages 947-956

  Schoppmann, Sebastian F ^a   Birner, Peter ^a   Stöckl, Johannes ^a   Kalt, Romana ^a   Ullrich, Robert ^a   Caucig, Carola ^a   Nagy, Katalin ^a   Alitalo, Kari ^b   Kerjaschki, Dontscho ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD23 ANTIGEN; CD68 ANTIGEN; LIPOPOLYSACCHARIDE; PROTEIN TYROSINE KINASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN C; VASCULOTROPIN D; VASCULOTROPIN RECEPTOR 3;

ANGIOGENESIS; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHANGIOMA; MONOCYTE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR ASSOCIATED LEUKOCYTE; UTERINE CERVIX CANCER;

EID: 0036733564     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64255-1     Document Type: Article

References (43)

1. Lymphatic vessels as targets of tumor therapy?
2. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development
3. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Fit4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases
4. Molecular cloning of a novel vascular endothelial growth factor, VEGF-D
5. Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors
6. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis
7. Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth
8. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis
9. Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma
10. Absence of functional lymphatics within a murine sarcoma: A molecular and functional evaluation
11. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: Podoplanin as a specific marker for lymphatic endothelium
12. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan
13. Angiogenesis in cancer and other diseases
14. Lymphatic microvessel density as a novel prognostic factor in early-stage invasive cervical cancer
15. Lymphatic microvessel density and lymphovascular invasion assessed by antipodoplanin immunostaining in human breast cancer
16. Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors
17. Inflammatory stroma reaction correlates with lymphatic microvessel density in early-stage cervical cancer
18. In situ hybridization with digoxigenin-labeled probes: Sensitive and reliable detection method applied to myelinating rat brain
19. Molecular and functional characteristics of dendritic cells generated from highly purified CD14+ peripheral blood monocytes
20. Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3
21. Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages
22. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice
23. Lymphatic vessels and lymphangiogenesis in female cancer: Mechanisms, clinical impact and possible implications for anti-lymphangiogenic therapies
24. The specificity of receptor binding by vascular endothelial growth factor-d is different in mouse and man
25. Proxl function is required for the development of the murine lymphatic system
26. Intratumoral lymphatic vessels: A case of mistaken identity or malfuntion
27. LYVE-1 is not restricted to the lymph vessels: Expression in normal liver blood sinusoids and down-regulation in human liver cancer and cirrhosis
28. Active interaction of human A375 melanoma cells with the lymphatics in vivo
29. Epitope-specific antibodies to the 43-kD glomerular membrane protein podoplanin cause proteinuria and rapid flattening of podocytes
30. Monoclonal antibody PAL-E specific for endothelium
31. Selective immunohistochemical staining of blood and lymphatic vessels reveals independent prognostic influence of blood and lymphatic vessel invasion in early-stage cervical cancer
32. Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer
33. High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas
34. Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features
35. Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues
36. Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis
37. Proteolytic processing regulates receptor specificity and activity of VEGF-C
38. CD123 (interleukin 3 receptor alpha chain)
39. Peripheral blood platelets express VEGF-C and VEGF which are released during platelet activation
40. Co-Expression of VEGF-C and its receptors, VEGFR-2 and VEGFR-3, in endothelial cells of lymphangioma implication in autocrine or paracrine regulation of lymphangioma
41. Expression of vascular endothelial growth factor in human monocyte/macrophages stimulated with lipopolysaccharide
42. In vitro activation of a human macrophage-like cell line
43. Dendritic cells derived from peripheral monocytes express endothelial markers and in the presence of angiogenic growth factors differentiate into endothelial-like cells